(Q35089529)

6 August 2017

1 reference

title

Prevention of variceal rebleeding. (English)

1 reference

6 August 2017

1 reference

Jaume Bosch

1

1 reference

6 August 2017

Juan Carlos García-Pagán

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

361

1 reference

6 August 2017

9361

1 reference

6 August 2017

952-954

1 reference

Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Complications of cirrhosis. I. Portal hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Transjugular intrahepatic portosystemic shunt versus endoscopic therapy: randomized trials for secondary prophylaxis of variceal bleeding: an updated meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Endoscopic treatments for portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Pharmacological treatment of portal hypertension: an evidence-based approach

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Long-term haemodynamic effects of isosorbide 5-mononitrate in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Isosorbide mononitrate in the prevention of first variceal bleed in patients who cannot receive beta-blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Predictive value of the variceal pressure response to continued pharmacological therapy in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

"A La Carte" treatment of portal hypertension: Adapting medical therapy to hemodynamic response for the prevention of bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912778-X

7 January 2021

10.1016/S0140-6736(03)12778-X

Identifiers

DOI

1 reference

release_zi3v5ks2hrgp3ht7nhz6pluy2a

6 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zi3v5ks2hrgp3ht7nhz6pluy2a

24 November 2022

mapped directly with Wikidata item

1 reference